135 related articles for article (PubMed ID: 16354458)
1. Decade-long use of continuous combined hormone replacement therapy is associated with better health-related quality of life in postmenopausal women, as measured by the generic 15D instrument.
Ylikangas S; Sintonen H; Heikkinen J
J Br Menopause Soc; 2005 Dec; 11(4):145-51. PubMed ID: 16354458
[TBL] [Abstract][Full Text] [Related]
2. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings.
Heikkinen J; Vaheri R; Timonen U
J Br Menopause Soc; 2006 Sep; 12(3):115-25. PubMed ID: 16953985
[TBL] [Abstract][Full Text] [Related]
3. A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women.
Heikkinen J; Vaheri R; Haapalahti J; Timonen U
Menopause Int; 2008 Jun; 14(2):70-7. PubMed ID: 18519268
[TBL] [Abstract][Full Text] [Related]
4. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of continuous combined hormone replacement therapy in long-term use: economic evaluation based on a 9-year study in Finland.
Ylikangas S; Bäckström T; Heikkinen J
Curr Med Res Opin; 2007 Jan; 23(1):57-64. PubMed ID: 17257466
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life.
Voss S; Quail D; Dawson A; Bäckström T; Aguas F; Erenus M; The HS; Bonnar J; De Geyter C; Hunter M; Nickelsen T;
BJOG; 2002 Aug; 109(8):874-85. PubMed ID: 12197366
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Diaby V; Perreault S; Lachaine J
Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
[TBL] [Abstract][Full Text] [Related]
11. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy.
Johnson JV; Davidson M; Archer D; Bachmann G
Menopause; 2002; 9(1):16-22. PubMed ID: 11791082
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.
Hall G; Pripp U; Schenck-Gustafsson K; Landgren BM
Maturitas; 1998 Jan; 28(3):235-42. PubMed ID: 9571599
[TBL] [Abstract][Full Text] [Related]
15. The impact of chronic orofacial pain on health-related quality of life.
Forssell H; Sipilä K; Teerijoki-Oksa T; Vartiainen P; Kautiainen H; Sintonen H; Kalso E
Scand J Pain; 2020 Apr; 20(2):329-338. PubMed ID: 31881002
[TBL] [Abstract][Full Text] [Related]
16. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
17. A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
Smolders RG; Vogelvang TE; Mijatovic V; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P; van der Mooren MJ
Maturitas; 2002 Feb; 41(2):105-14. PubMed ID: 11836041
[TBL] [Abstract][Full Text] [Related]
18. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
[TBL] [Abstract][Full Text] [Related]
19. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement therapy among postmenopausal women and its effects on signs and symptoms of temporomandibular disorders.
Nekora-Azak A; Evlioglu G; Ceyhan A; Keskin H; Berkman S; Issever H
Cranio; 2008 Jul; 26(3):211-5. PubMed ID: 18686498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
